Finance

Roʻyxatlar
GH:NASDAQ
Guardant Health Inc
177,73 US$
+0,23%
(+0,40) 1K
177,73 US$
0,00% (0,00)
Yopilgandan keyin
Savdolar yopilgan: 29-sen, 16:00:01 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
GH tikeri uchun statistika yaratilmoqda...
Ochish
176,78 US$
Yuqori
180,90 US$
Past
174,54 US$
Bozor kapitali
23,85 mlrd
Oʻrtacha hajm
1,96 mln
Hajmi
1,66 mln
52 haftalik eng yuqori
183,51 US$
52 haftalik eng past
60,46 US$
Aksiya boʻyicha daromad
-3,50 US$
Beta
1,57
Muomaladagi aksiyalar
134,20 mln
Xodimlar soni
2 ming
Ochish
176,78 US$
Yuqori
180,90 US$
Past
174,54 US$
Bozor kapitali
23,85 mlrd
Oʻrtacha hajm
1,96 mln
Hajmi
1,66 mln
52 haftalik eng yuqori
183,51 US$
52 haftalik eng past
60,46 US$
Aksiya boʻyicha daromad
-3,50 US$
Beta
1,57
Muomaladagi aksiyalar
134,20 mln
Xodimlar soni
2 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Guardant Health Inc haqida
CEOHelmy Eltoukhy | AmirAli Talasaz
Xodimlar soni2,5 ming
Asos solingan2012
Bosh ofislarPalo-Alto, Kaliforniya, Amerika Qo‘shma Shtatlari
SektorHealth care provider
Analitik reytinglar
Oxirgi 3 oyda GH aksiyalari boʻyicha reyting bergan 22 tahlilchi xulosasiga koʻra
Sotib olish tavsiya etiladi
Sotib olish
22
Ushlab qolish
0
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda GH uchun 12 oylik narx maqsadlarini taklif qilgan 22 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 177,73 US$
225,00 US$ (+26,60%)
O‘rtacha
197,42 US$ (+11,08%)
Eng past
125,00 US$ (-29,67%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Eve Burstein
Bernstein
Buy
Maintained
210,00 US$
+18,2%
09/25/2026
Evie Koslosky
Goldman Sachs
Buy
Maintained
225,00 US$
+26,6%
09/20/2026
Luke Sergott
Barclays
Buy
Maintained
200,00 US$
+12,5%
09/18/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
09/15/2026
David Westenberg
Piper Sandler
Buy
Maintained
193,00 US$
+8,6%
09/15/2026
Unknown Analyst
UBS
Buy
Maintained
225,00 US$
+26,6%
09/09/2026
Doug Schenkel
UBS
Buy
Maintained
225,00 US$
+26,6%
09/09/2026
Jamie Clark
Rothschild & Co Redburn
Buy
Initiated
203,00 US$
+14,2%
09/08/2026
Matt Larew
William Blair
Buy
Maintained
-
-
09/08/2026
Mark Massaro
BTIG
Buy
Reiterated
195,00 US$
+9,7%
09/01/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
195,00 US$
+9,7%
08/04/2026
Bradley Bowers
Mizuho Securities
Buy
Maintained
200,00 US$
+12,5%
08/04/2026
Mason Carrico
Stephens
Buy
Maintained
195,00 US$
+9,7%
08/04/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Reiterated
185,00 US$
+4,1%
08/04/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
205,00 US$
+15,3%
08/02/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
180,00 US$
+1,3%
08/03/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
-
-
07/31/2026
Dan Leonard
RBC Capital
Buy
Reiterated
200,00 US$
+12,5%
07/31/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
210,00 US$
+18,2%
07/31/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
190,00 US$
+6,9%
07/31/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
125,00 US$
-29,7%
07/29/2026
Patrick B Donnelly
Citi
Buy
Maintained
215,00 US$
+21%
07/08/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
200,00 US$
+12,5%
07/06/2026
Puneet Souda
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Paige Chamberlain‏
Wolfe Research
Buy
Reiterated
150,00 US$
-15,6%
06/01/2026
Unknown Analyst
Wolfe Research
Buy
Reiterated
150,00 US$
-15,6%
06/01/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/27/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
129,00 US$
-27,4%
05/08/2026
Andrew Cooper
Raymond James
Buy
Reiterated
129,00 US$
-27,4%
02/23/2026
Oxirgi hisobot
30-iyl, 2026
Moliya davri
Ch.2 2026
Aksiya boʻyicha taxminiy daromad (USD)
-0,42 US$ / -0,39 US$
-7,81%manfiy
Taxminiy daromad (USD)
334,98 mln / 314,43 mln
+6,53%musbat
Q2 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
265,20 mln
281,27 mln
301,66 mln
334,98 mln
Sotilgan mahsulotning tannarxi
93,59 mln
99,49 mln
104,92 mln
115,95 mln
Daromad narxi
93,59 mln
99,49 mln
104,92 mln
115,95 mln
Tadqiqot va ishlanmalarga xarajatlar
89,96 mln
98,26 mln
91,04 mln
96,53 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
180,53 mln
204,20 mln
227,06 mln
250,61 mln
Operatsion xarajatlar
270,48 mln
302,46 mln
318,10 mln
347,15 mln
Jami operatsion xarajatlar
364,07 mln
401,96 mln
423,02 mln
463,10 mln
Operatsion daromad
-98,87 mln
-120,69 mln
-121,35 mln
-128,12 mln
Boshqa nooperatsion daromad
-48,00 ming
-4,69 mln
1,55 mln
308,00 ming
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-92,59 mln
-130,22 mln
-111,70 mln
-119,96 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-92,47 mln
-116,52 mln
-111,70 mln
-118,96 mln
Daromad soligʻi boʻyicha xarajat
136,00 ming
-1,73 mln
372,00 ming
185,00 ming
Amaldagi soliq stavkasi
-0,15%
1,33%
-0,33%
-0,15%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-92,72 mln
-128,49 mln
-112,08 mln
-120,14 mln
Sof foyda marjasi
-34,96%
-45,68%
-37,15%
-35,87%
Har bir aksiya foydasi
-0,39
-0,50
-0,45
-0,42
Foizlar va investitsiyalardan olingan daromadlar
7,39 mln
10,03 mln
11,15 mln
10,20 mln
Foizlarni toʻlash xarajatlari
-943,00 ming
-1,18 mln
-3,05 mln
-1,35 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
6,45 mln
8,85 mln
8,10 mln
8,85 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-89,47 mln
-110,64 mln
-111,91 mln
-118,56 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maʼlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari